Extracellular calcium sensing receptor: An overview of physiology, pathophysiology and clinical perspectives

In Vivo

Volumn 18, Issue 6, 2004, Pages 739-754

  Msaouel, P ^a   Nixon, A M ^a   Bramos, A P ^a   Baiba, E ^a   Kentarchos, N E ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Calcimimetics; Calcium homeostasis; Calcium receptor; Hypercalcaemia

Indexed keywords

2 CHLORO 6 [3 [1,1 DIMETHYL 2 (2 NAPHTHYL)ETHYLAMINO] 2 HYDROXYPROPOXY]BENZONITRILE; AMINO ACID; AMINO ACID DERIVATIVE; AMINOGLYCOSIDE; CALCIMIMETIC AGENT; CALCITONIN; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; CALCIUM SENSING RECEPTOR; CALHEX 231; CINACALCET; FUROSEMIDE; GENTAMICIN; N [3 (2 CHLOROPHENYL)PROPYL] 1 (3 METHOXYPHENYL)ETHYLAMINE; NEOMYCIN; PAMIDRONIC ACID; PHOSPHATE BINDING AGENT; POLYAMINE DERIVATIVE; TOBRAMYCIN; UNCLASSIFIED DRUG; VITAMIN D;

BONE DISEASE; CALCIUM HOMEOSTASIS; CELL TYPE; CHEMICAL ANALYSIS; CLINICAL TRIAL; DRUG BIOAVAILABILITY; DRUG HALF LIFE; DRUG RESEARCH; EXTRACELLULAR CALCIUM; FAMILIAL HYPOCALCIURIC HYPERCALCEMIA; GENETIC DISORDER; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; HYPOCALCEMIA; HYPOCALCIURIA; MEDICAL RESEARCH; MOLECULAR CLONING; NAUSEA; NEPHROTOXICITY; PARESTHESIA; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SECONDARY HYPERPARATHYROIDISM;

EID: 11844269906     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (153)

1. Brown EM and MacLeod RJ: Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 81: 239-297, 2001.
2. Felder CB, Graul RC, Lee AY, Merkle HP and Sadee W: The Venus Flytrap of periplasmic binding proteins: an ancient protein module present in multiple drug receptors. AAPS PharmSci 1: 1-20, 1999
3. Chikatsu N, Fukumoto S, Takeuchi Y et al: Cloning and characterization of two promoters for the human calcium-sensing receptor (CaSR) and changes of CaSR expression in parathyroid adenomas. J Biol Chem 275: 7553-7557, 2000.
4. Canaff L and Hendy GN: Human calcium-sensing receptor gene: Vitamin D response elements in promoters P1 and P2 confer transcriptional responsiveness to 1,25-dihydroxyvitamin D. J Biol Chem 277: 30337-30350, 2002.
5. 2+-sensing receptor: implications for its structure and function. Trends Endocrinol Metab 14: 282-288, 2003.
6. Goldsmith PK, Fan GF, Ray K et al: Expression, purification, and biochemical characterization of the amino-terminal extracellular domain of the human calcium receptor. J Biol Chem 274 11303-11309, 1999.
7. 2+ receptor extracellular domain: Analysis of function of lobe I loop deletion mutants. J Biol Chem 276: 32145-32151, 2001.
8. 136 region in the calcium-sensing receptor: Constitutive activity and inverse agonism in a family C G-protein-coupled receptor. J Biol Chem 275: 29547-29555, 2000.
9. Hu J, Mora S, Colussi G, Proverbio MC et al: Autosomal dominant hypocalcemia caused by a novel mutation in the loop 2 region of the human calcium receptor extracellular domain. J Bone Miner Res 17 1461-1469, 2002.
10. 2+ receptor. J Biol Chem 274: 27642-27650, 1999.
11. 2+ receptor: effects on cell surface expression, dimerization and signal transduction. FEBS Lett 436: 353-356, 1998.
12. Hu J, Reyes-Cruz G, Goldsmith PK and Spiegel AM: The Venus's-flytrap and cysteine-rich domains of the human calcium receptor are not linked by disulfide bonds. J Biol Chem 276: 6901-6904, 2001.
13. 2+ receptor cysteine-rich domain: Analysis of function of mutant and chimeric receptors. J Biol Chem 275: 16382-16389, 2000.
14. Pace AJ, Gama L and Breitwieser GE: Dimerization of the calcium-sensing receptor occurs within the extracellular domain and is eliminated by Cys → Ser mutations at Cys101 and Cys236. J Biol Chem 274: 11629-11634, 1999.
15. Zhang Z, Sun S, Quinn SJ, Brown EM and Bai M: The extracellular calcium-sensing receptor dimerizes through multiple types of intermolecular interactions. J Biol Chem 276: 5316-5322, 2001
16. Gama L, Wilt SG and Breitwieser GE: Heterodimerization of calcium sensing receptors with metabotropic glutamate receptors in neurons. J Biol Chem 276: 39053-39059, 2001.
17. Bai M, Triverdi S, Kifor O, Quinn SJ and Brown EM: Intermolecular interactions between dimeric calcium-sensing receptor monomers are important for its normal function. Proc Natl Acad Sci 96 2834-2839, 1999.
18. Miedlich S, Gama L and Breitwieser GE: Calcium sensing receptor activation by a calcimimetic suggests a link between cooperativity and intracellular calcium oscillations. J Biol Chem 277 49691-49699, 2002.
19. Zhang Z, Qiu W, Quinn SJ, Conigrave AD, Brown EM and Bai M: Three adjacent serines in the extracellular domains of the CaR are required for L-amino acid-mediated potentiation of receptor function. J Biol Chem 277: 33727-33735, 2002.
20. Zhang Z, Jiang Y, Quinn SJ, Krapcho K, Nemeth EF and Bai M: L-Phenylalanine and NPS-467 synergistically potentiate the function of the extracellular calcium-sensing receptor through distinct sites. J Biol Chem 277: 33736-33741, 2002.
21. Hofer AM and Brown EM: Extracellular calcium sensing and signaling. Nat Rev Mol Cell Biol 4: 530-538, 2003.
22. 2+ receptor. J Biol Chem 277: 18908-18913, 2002.
23. 2+-sensing receptor. Am J Physiol Cell Physiol 282: C1414-C1422, 2002.
24. Ray K, Fan GF, Goldsmith PK and Spiegel AM: The carboxyl terminus of the human calcium receptor: Requirements for cell-surface expression and signal transduction. J Biol Chem 272: 31355-31361, 1997.
25. 2+ and a positive allosteric modulator. J Biol Chem 277: 46622-46631, 2002.
26. Hauache OM: Extracellular calcium-sensing receptor: structural and functional features and association with diseases. Braz J Med Biol Res 34: 577-584, 2001.
27. 2+ receptor in cell surface expression and receptor activation processes. Endocrinology (April 29, 2004, ahead of print)
28. 2+ receptor /metabotropic glutamate chimeric receptors. Endocrinology 141: 4156-4163, 2000.
29. 2+ receptor antagonists that stimulate secretion of parathyroid hormone. J Pharmacol Exp Ther 299 323-331, 2001.
30. 2+-sensing receptor mediate efficient cell-surface expression and phospholipase C activation. J Biol Chem 276: 44129-44136, 2001.
31. o-sensing receptor (CaR) modulates functional interaction of G proteins with the CaR cytoplasmic tail. J Biol Chem 277: 50543-50549, 2002.
32. 2+ activation of the human calcium sensing receptor: A study with receptor-green fluorescent protein fusions. J Biol Chem 273: 29712-29718, 1998.
33. Awata H, Huang C, Handlogten ME and Miller RT: Interaction of the calcium-sensing receptor and filamin, a potential scaffolding protein. J Biol Chem 276: 34871-34879, 2001.
34. Hjälm G, MacLeod RG, Kifor O, Chattopadhyay N and Brown EM: Filamin-A binds to the carboxyl-terminal tail of the calcium-sensing receptor, an interaction that participates in CaR-mediated activation of mitogen-activated protein kinase. J Biol Chem 276: 34880-34887, 2001.
35. Lienhardt A, Garabédian M, Bai M et al: A large homozygous or heterozygous in-frame deletion within the calcium-sensing receptor's carboxylterminal cytoplasmic tail that causes autosomal dominant hypocalcemia. J Clin Endocrinol Metab 85: 1695-1702, 2000.
36. 2+-sensing receptor require negative feedback by protein kinase C. J Biol Chem 277: 46871-46876, 2002.
37. 2+)-sensing receptor from bovine parathyroid. Nature 366: 575-80, 1993.
38. Garrett JE, Capuano IV, Hammerland LG et al: Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs. J Biol Chem 270: 12919-12925, 1995.
39. Ruat M, Molliver ME, Snowman AM and Snyder SH: Calcium sensing receptor: molecular cloning in rat and localization to nerve terminals. Proc Natl Acad Sci USA 92: 3161-3165, 1995.
40. 2+)-sensing receptor. Am J Kidney Dis 25: 506-513, 1995.
41. Garrett JE, Tamir H, Kifor O et al: Calcitonin-secreting cells of the thyroid express an extracellular calcium receptor gene. Endocrinology 136: 5202-5211, 1995.
42. Toribio RE, Kohn CW, Capen CC and Rosol TJ: Parathyroid hormone (PTH) secretion, PTH mRNA and calcium-sensing receptor mRNA expression in equine parathyroid cells, and effects of interleukin (IL)-1, IL-6, and tumor necrosis factor-alpha on equine parathyroid cell function. J Mol Endocrinol 31: 609-620, 2003.
43. Roussanne MC, Lieberherr M, Souberbielle JC, Sarfati E, Drueke T and Bourdeau A: Human parathyroid cell proliferation in response to calcium, NPS R-467, calcitriol and phosphate. Eur J Clin Invest 31 610-616, 2001.
44. Ward DT, McLarnon SJ and Riccardi D: Aminoglycosides increase intracellular calcium levels and ERK activity in proximal tubular OK cells expressing the extracellular calcium-sensing receptor. J Am Soc Nephrol 13: 1481-1489, 2002.
45. Godwin SL and Soltoff SP: Calcium-sensing receptor-mediated activation of phospholipase C-gamma1 is downstream of phospholipase C-beta and protein kinase C in MC3T3-E1 osteoblasts. Bone 30: 559-566, 2002.
46. 2+-sensing receptor. J Mol Endocrinol 21: 7-17, 1998.
47. Tfelt-Hansen J, Chattopadhyay N, Yano S et al: Calcium-sensing receptor induces proliferation through p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase but not extracellularly regulated kinase in a model of humoral hypercalcemia of malignancy. Endocrinology 145: 1211-1217, 2004.
48. Tfelt-Hansen J, MacLeod RJ, Chattopadhyay N et al: Calcium-sensing receptor stimulates PTHrP release by pathways dependent on PKC, p38 MAPK, JNK, and ERK1/2 in H-500 cells. Am J Physiol Endocrinol Metab 285: E329-337, 2003.
49. Kifor O, MacLeod RJ, Diaz R et al: Regulation of MAP kinase by calcium-sensing receptor in bovine parathyroid and CaR-transfected HEK293 cells. Am J Physiol Renal Physiol 280: F291-302, 2001.
50. Quitterer U, Hoffmann M, Freichel M and Lohse MJ: Paradoxical block of parathormone secretion is mediated by increased activity of G alpha subunits. J Biol Chem 276: 6763-6769, 2001.
51. 2+ receptor-stimulated hormone release from sheep thyroid parafollicular cells. J Physiol 502(Pt 1) 31-44, 1997.
52. MacLeod RJ, Chattopadhyay N and Brown EM: PTHrP stimulated by the calcium-sensing receptor requires MAP kinase activation. Am J Physiol Endocrinol Metab 284: E435-442, 2003.
53. 2+ -sensing receptor in rat intestine. Am J Physiol 274 (1 Pt 1): G122-130, 1998.
54. o -sensing receptor in the clonal osteoblast-like cell lines, UMR-106 and SAOS-2. Biochem Biophys Res Commun 243: 753-757, 1998.
55. 2+/polyvalent cation-sensing protein in rat kidney. Am J Physiol 274(3 Pt 2): F611-622, 1998.
56. Ba J, Brown D and Friedman PA: Calcium-sensing receptor regulation of PTH-inhibitable proximal tubule phosphate transport. Am J Physiol Renal Physiol 285: F1233-1243, 2003.
57. Kos CH, Karaplis AC, Peng JB et al: The calcium-sensing receptor is required for normal calcium homeostasis independent of parathyroid hormone. J Clin Invest 111: 1021-8, 2003.
58. Wang D, Pedraza PL, Abdullah HI, McGiff JC and Ferreri NR: Calcium-sensing receptor-mediated TNF production in medullary thick ascending limb cells. Am J Physiol Renal Physiol 283: F963-970, 2002.
59. Motoyama HI and Friedman PA: Calcium-sensing receptor regulation of PTH-dependent calcium absorption by mouse cortical ascending limbs. Am J Physiol Renal Physiol 283: F399-406, 2002.
60. Speer G, Cseh K, Fuszek P et al: The role of estrogen receptor, vitamin D receptor and calcium receptor genotypes in the pathogenesis of colorectal cancer. Orv Hetil 142: 947-951, 2001.
61. Yamaguchi T, Chattopadhyay N, Kifor O et al: Expression of extracellular calcium-sensing receptor in human osteoblastic MG-63 cell line. Am J Physiol Cell Physiol 280: C382-C393, 2001.
62. Ye CP, Yamaguchi T, Chattopadhyay N, Sanders JL, Vassilev PM and Brown EM: Extracellular calcium-sensing-receptor (CaR)-mediated opening of an outward K(+) channel in murine MC3T3-E1 osteoblastic cells: evidence for expression of a functional CaR. Bone 27: 21-27, 2000.
63. 2+(o) on the function of ST2 cells. Endocrinology 139: 3561-3568, 1998.
64. Kameda T, Mano H, Yamada Y et al: Calcium-sensing receptor in mature osteoclasts, which are bone resorbing cells. Biochem Biophys Res Commun 245: 419-422, 1998.
65. Lorget F, Kamel S, Mentaverri R et al: High extracellular calcium concentrations directly stimulate osteoclast apoptosis. Biochem Biophys Res Commun 268: 899-903, 2000.
66. 2+ sensing receptor activation in the growth plate. FASEB J 18: 143-145, 2004.
67. Chang W, Tu C, Bajra R et al: Calcium sensing in cultured chondrogenic RCJ3.1C5.18 cells. Endocrinology 140: 1911-1919, 1999.
68. Dvorak MM, Siddiqua A, Ward DT et al: Physiological changes in extracellular calcium concentration directly control osteoblast function in the absence of calciotropic hormones. Proc Natl Acad Sci USA 101: 5140-5145, 2004.
69. Chang W, Tu C, Chen T et al: Expression and signal transduction of calcium-sensing receptors in cartilage and bone. Endocrinology 140: 5883-5893, 1999.
70. 2+) influx through the osteoclastic plasma membrane ryanodine receptor. Am J Physiol Renal Physiol 282: F921-932, 2002.
71. Shiraishi N, Kitamura K, Kohda Y et al: Increased endothelin-1 expression in the kidney in hypercalcemic rats. Kidney Int 63: 845-852, 2003.
72. 2+)-sensing receptor in the human placenta. Placenta 23: 192-200, 2002.
73. Wang W, Li C, Kwon TH et al: Reduced expression of renal Na+ transporters in rats with PTH-induced hypercalcemia. Am J Physiol Renal Physiol 286: F534-545, 2004.
74. Chattopadhyay N, Yano S, Tfelt-Hansen J et al: Mitogenic action of calcium-sensing receptor on rat calvarial osteoblasts. Endocrinology. Apr 7 2004 [Epub ahead of print]
75. Carpenter TO, Insogna KI, Boulware SD and Mitnick MA: Vitamin D metabolism in chronic childhood hypoparathyroidism: evidence for a direct regulatory effect of calcium. J Pediatr 269: 252-257, 1990.
76. Pi M and Quarles LD: A novel cation-sensing mechanism in osteoblasts is a molecular target for strontium. J Bone Miner Res 19 862-869, 2004.
77. Shalhoub V, Grisanti M, Padagas J et al: In vitro studies with the calcimimetic, cinacalcet HCl, on normal human adult osteoblastic and osteoclastic cells. Crit Rev Eukaryot Gene Expr 13 89-106, 2003.
78. Kamioka H, Sumitani K, Tagami K et al: Divalent cations elevate cytosolic calcium of chick osteocytes. Biochem Biophys Res Commun 204: 519-524, 1994.
79. Chattopadhyay N, Legradi G, Bai M et al: Calcium-sensing receptor in the rat hippocampus: a developmental study. Brain Res Dev Brain Res 100: 13-21, 1997.
80. Simpson JB and Routenberg A: Subfornical organ lesions reduce intravenous angiotensin-induced drinking. Brain Res 88: 154-161, 1975.
81. Chattopadhyay N: Biochemistry, physiology and pathophysiology of the extracellular calcium-sensing receptor. Int J Biochem Cell Biol 32: 789-804, 2000.
82. 2+-sensing receptor gene. Brain Res Bull 44 75-84, 1997.
83. Ye C, Kanazirska M, Quinn S, Brown EM and Vassilev PM: Modulation by polycationic Ca21-sensing receptor agonists of nonselective cation channels in rat hippocampal neurons. Biochem Biophys Res Commun 224: 271-280, 1996.
84. Chattopadhyay N, Ye CP, Yamaguchi T et al: Extracellular calcium-sensing receptor in rat oligodendrocytes: expression and potential role in regulation of cellular proliferation and an outward K1 channel. Glia 24: 449-458, 1998.
85. 2+-sensing receptor in human astrocytes, astrocytomas, and meningiomas. Am J Physiol 279: 691-699, 2000.
86. Chattopadhyay N, Ye C, Yamaguchi T et al: The extracellular calcium-sensing receptor is expressed in rat microglia and modulates an outward K1 channel. J Neurochem 72: 1915-1922, 1999.
87. McNeil SE, Hobson S, Nipper V and Roland KD: Functional calcium-sensing receptors in rat fibroblasts are required for activation of SRC kinase and mitogen-activated protein kinase in response to extracellular calcium. J Biol Chem 273: 1114-1120, 1998.
88. McNeil L, Hobson S, Nipper V and Roland KD: Functional calcium-sensing receptor expression in ovarian surface epithelial cells. Am J Obstet Gynecol 178: 305-313, 1998.
89. Bikle D, Ratnam A, Mauro T, Harris J and Pillai S: Changes in calcium responsiveness and handling during keratinocyte differentiation. Potential role of the calcium receptor. J Clin Invest 97: 1085-1093, 1996.
90. Tu CL, Chang W and Bikle D: The extracellular calcium-sensing receptor is required for calcium-induced differentiation in human keratincytes. J Biol Chem 276: 41079-41085, 2001.
91. Bikle D, Ng D, Tu CL, Oda Y and Xie Z: Calcium- and vitamin D-regulated keratinocyte differentiation. Mol Cell Endocrinol 177: 161-171, 2001.
92. Komunes L, Oda Y, Tu C et al: Epidermal expression of the full-length extracellular calcium-sensing receptor is required for normal keratinocyte differentiation. J Cell Physiol 192: 45-54, 2002.
93. Fatherazi S, Belton C, Cai S et al: Calcium receptor message, expression and function decrease in differentiating keratinocytes. Pflugers Arch 448: 93-104, 2004.
94. Chattopadhyay N, Ye C, Singh DP et al: Expression of extracellular calcium-sensing receptor by human lens epithelial cells. Biochem Biophys Res Commun 233: 801-805, 1997.
95. Wang R, Xu C, Zhao W, Zhang J, Cao K, Yang B and Wu L: Calcium and polyamine regulated calcium-sensing receptors in cardiac tissues. Eur J Biochem 270: 2680-2688, 2003.
96. Cheng I, Klingensmith ME, Chattopadhyay N et al: Identification and localization of the extracellular calcium-sensing receptor in human breast. J Clin Endocrinol Metab 83: 703-707, 1998.
97. VanHouten J, Dann P, McGeoch G et al: The calcium-sensing receptor regulates mammary gland parathyroid hormone-related protein production and calcium transport. J Clin Invest 113: 598-608, 2004.
98. Emanuel RL, Adler GK, Kifor O et al: Calcium-sensing receptor expression and regulation by extracellular calcium in the AtT-20 pituitary cell line. Mol Endocrinol 10: 555-565, 1996.
99. Romoli R, Lania A, Mantovani G, Corbetta S, Persani L and Spada A: Expression of calcium-sensing receptor and characterization of intracellular signaling in human pituitary adenomas. J Clin Endocrinol Metab 84: 2848-2853, 1999.
100. 2+-sensing receptor in melanotrope cells of Xenopus laevis. Endocrinology 144: 2524-2533, 2003.
101. +2-sensing receptor (CaR) in endocrine tissues. J Endocrinol 165: 173-177, 2000.
102. 2+-sensing receptors in intestinal epithelium. Am J Physiol Cell Physiol 273: C1168-C1175, 1997.
103. Sheinin Y, Kallay E, Wrba F, Kriwanek S, Peterlik M and Cross H: Immunocytochemistry localization of the extracellular calcium-sensing receptor in normal and malignant human large intestinal mucosa. J Histochem Cytochem 48: 595-601, 2000.
104. Cheng S, Okuda M, Hall AE, Geibel JP and Hebert S: Expression of calcium-sensing receptor in rat colonic epithelium: evidence for modulation of fluid secretion. Am J Physiol Gastrointest Liver Physiol 283: G240-G250, 2002.
105. House MG, Kohlmeier L, Chattopadhyay N et al: Expression of an extracellular calcium-sensing receptor in human and mouse bone marrow cells. J Bone Miner Res 12: 1959-1970, 1997.
106. Yamaguchi T, Ye CP, Chattopadhyay N, Sanders JL, Vassilev PM and Brown EM: Enhanced expression of extracellular calcium sensing receptor in monocyte-differentiated versus undifferentiated HL-60 cells: Potential role in regulation of a nonselective cation channel. Calcified Tissue Int 66: 375-382, 2000.
107. Canaff L, Petit JL, Kisiel M, Watson P, Gascon-Barre M and Hendy GN: Extracellular calcium-sensing receptor is expressed in rat hepatocytes coupling to intracellular mobilization and stimulation of bile flow. J Biol Chem 276: 4070-4079, 2001.
108. Nearing J, Betka M, Quinn S et al: Polyvalent cation receptor proteins (CaRs) are salinity sensors in fish. Proc Natl Acad Sci 99: 9231-9236, 2002.
109. Quarles LD: Extracellular calcium-sensing receptors in the parathyroid gland, kidney and other tissues. Curr Opin Nephrol Hypertens 12: 349-355, 2003.
110. Pearce SHS and Brown EM: Disorders of calcium ion sensing. J Clin Endocrinol Metab 81: 2030-2035, 1996.
111. Heath H: Familial benign (hypocalciuric) hypercalcaemia, a troublesome mimic of mild primary hyperparathyroidism. Endocrinol Metab Clin North Am 18: 723-740, 1989.
112. Pearce SHS: Clinical disorders of extracellular calcium-sensing and the molecular biology of the calcium-sensing receptor. Ann Med 34: 201-206, 2002.
113. 2+-sensing receptor gene that cause familial hypocalciuric hypercalcaemia. Am J Hum Genet 56: 1075-1079, 1995.
114. 2+ receptor. J Biol Chem 271: 19537-19545, 1996.
115. Hendy NG, De Souza L, Yang B et al: Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hyper-calcemia, neonatal severe hyper-parathyroidism and autosomal dominant hypocalcemia. Human Mutation 16: 281-296, 2000.
116. 2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia. J Clin Invest 99: 88-96, 1997.
117. Brown EM: Physiology and pathophysiology of the extracellular calcium-sensing receptor. Am J Med 106: 238-253, 1999.
118. Khosla S, Ebeling PR, Firek AF et al: Calcium infusion suggests a "set-point" abnormality of parathyroid gland function in familial benign hypercalcemia and more complex disturbances in primary hyperparathyroidism. J Clin Endocrinol Metab 76: 715-720, 1993.
119. Pollak M, Chou YH, Marx SJ et al: Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype. J Clin Invest 93: 1108-1112, 1994.
120. Pearce SHS, Williamson C, Kifor O et al: A familial syndrome of hypocalcaemia with hypercalciuria due to mutations in the calcium-sensing receptor gene. N Engl J Med 335: 1115-22, 1996.
121. Yamamoto M, Akatsu T, Nagase T and Ogata E: Comparison of hypocalcemic hypercalciuria between patients with idiopathic hypo-parathyroidism and those with gain-of-function mutations in the calcium sensing receptor: is it possible to differentiate the two disorders? J Clin Endocrinol Metab 85: 4583-4591, 2000.
122. Kifor O, Moore FD, Delaney M et al: A syndrome of hypocalciuric hypercalcaemia caused by autoantibodies directed at the calcium-sensing receptor. J Clin Endocrinol Metab 88: 60-72, 2003.
123. Vargas-Poussou R, Huang C, Hulin P et al: Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter -like syndrome. J Am Soc Nephrol 13: 2259-2266, 2002.
124. Watanabe S, Fukumoto S, Chang H et al: Association between activating mutations of calcium-sensing receptor and Bartter's syndrome. Lancet 360: 692-694, 2002.
125. Sayer JA and Pearce SHS: Extracellular calcium-sensing receptor dysfunction is associated with two new phenotypes. Clin Endocrinol 59: 419-421, 2003.
126. 2+-sensing receptor is a promiscuous divalent cation sensor that responds to lead. Am J Physiol Renal Physiol 279: F1083-F1091, 2000.
127. 2+-sensing receptor in divalent mineral ion homeostasis. J Exp Biol 200: 295-302, 1997.
128. 2+-sensing receptor: a target for polyamines. Am J Physiol 273: C1315-C1323, 1997.
129. Molitoris BA: Cell biology of aminoglycoside nephrotoxicity: newer aspects. Curr Opin Nephrol Hypertens 6: 384-388, 1997.
130. McLarnon S, Holden D, Ward DT et al: Aminoglycoside antibiotics induce pH-sensitive activation of the calcium-sensing receptor. Biochem Biophys Res Commun 297: 71-77, 2002.
131. 2+-sensing receptor. Proc Natl Acad Sci USA 97 4814-4819, 2000.
132. Kobilka B: Allosteric activation of the CaR by L-amino acids. Proc Natl Acad Sci USA 97: 4819-4820, 2000.
133. 2+ receptor expressed in Xenopus laevis oocytes by NPS 476 or NPS 568. Mol Pharmacol 53: 1083-1088, 1998.
134. Brauner-Osborne H, Jensen AA, Sheppard PO, O'Hara P and Krogsgaard-Larsen P: The agonist-binding domain of the calcium-sensing receptor is located at the amino-terminal domain. J Biol Chem 274: 18382-18386, 1999.
135. Knoflach F, Mutel V, Jolidon S et al: Positive allosteric modulators of metabotropic glutamate 1 receptor: characterization, mechanism of action, and binding site. Proc Natl Acad Sci USA 98: 13402-7, 2001.
136. 2+ receptor in rats. J Pharmacol Exp Ther 290 480-486, 1999.
137. Nemeth EF, Steffey ME, Hammerland LG et al: Calcimimetics with potent and selective activity on the parathyroid calcium receptor. Proc Natl Acad Sci USA 95: 4040-4045, 1998.
138. Silverberg SJ, Bone HG 3rd, Marriott TB et al: Short-term inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism. N Eng J Med 337: 1506-1510, 1997.
139. Antonsen JE, Sherrard DJ and Andress DL: A calcimimetic agent acutely suppresses parathyroid hormone levels in patients with chronic renal failure. Rapid communication. Kidney Int 53: 223-227, 1998.
140. Goodman WG, Frazao JM, Goodkin DA, Turner SA, Liu W and Coburn JW: A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism. Kidney Int 58: 436-445, 2000.
141. Collins MT, Skarulis MC, Bilezikian JP, Silverberg SJ, Spiegel AM and Marx SJ: Treatment of hypercalcemia secondary to parathyroid carcinoma with a novel calcimimetic agent. J Clin Endocrinol Metab 83: 1083-1088, 1998.
142. Goodman WG, Hladik GA, Turner SA et al: The calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism. J Am Soc Nephrol 13: 1017-1024, 2002.
143. Lindberg JS, Moe SM, Goodman WG et al: The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism. Kidney Int 63: 248-254, 2003.
144. Quarles LD, Sherrard DJ, Adler S et al: The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease. J Am Soc Nephrol 14 575-583, 2003.
145. Quarles LD, Spiegel D, Curzi M et al: The effects of one year treatment with the calcimimetic AMG-073 on bone health in ESRD patients with secondary hyperparathyroidism. (SHPT). J Am Soc Nephrol 13: 572A-573A, 2002.
146. Goodman WG: Medical management of secondary hyperparathyroidism in chronic renal failure. Nephrol Dial Transplant 18: [Suppl 3] iii2-iii8, 2003.
147. Shoback DM, Bilezikian JP, Turner SA et al: The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism. J Clin Endocrinol Metab 88: 5644-5649, 2003.
148. Block GA, Martin KJ, de Francisco AL et al: Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 350: 1565-7, 2004.
149. 2+-sensing receptor. J Biol Chem 278: 49487-49494, 2003.
150. 2+-sensing receptor interact within overlapping but not identical binding sites in the transmembrane domain. J Biol Chem 279: 18990-7, 2004.
151. Kimmel DB, Bozzato RP, Kronis KA et al: The effect of recombinant human (1-84) or synthetic human (1-34) parathyroid hormone on the skeleton of adult ovariectomized rats. Endocrinology 132: 1577-1584, 1993.
152. Black DM, Greenspan SL, Ensrud KE et al: The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Eng J Med 349: 1207-15, 2003.
153. Finkelstein JS, Hayes A, Hunzelman JL, Wyland JJ, Lee H and Neer RM: The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N Eng J Med 349: 1216-26, 2003.